广东第一例机器人减重手术顺利完成,微创外科开启新的篇章!

2020-06-04 吴良平主任 吴良平主任

2020年6月3日,广东第一例达芬奇机器人减重手术在我院顺利完成,这对外科手术的发展起到重大的意义。

2020年6月3日,广东第一例达芬奇机器人减重手术在我院顺利完成,这对外科手术的发展起到重大的意义。

"手术安全吗?"

一直以来,减重手术的安全是很多咨询者重点关注的问题,与此同时医学界也一直在致力于外科手术的技术研究,为的就是让外科手术越来越安全和高效。其中,达芬奇机器人的出现让外科手术达到一个新的高度。

医疗界已经进入一个新的微创时代

传统的手术,医生必须自己拿着器械,在病人身边做手术,整个手术过程需要保持高度的专注,一台手术下来导致身心疲惫。这也是为什么我们一直强调主刀医生经验和技术的原因,因为这些因素直接联系到手术的安全和术后并发症的发生率。

33731591173505916

(传统腹腔镜手术)

而对比之下,达芬奇机器人的加入可以让操作的医生可以离开手术台,只需在一个控制台上面去控制机器臂就可以完成整个手术流程。

达芬奇机器人手术有什么优势呢?

1. 成像更清晰

与大多数传统腹腔镜的放大倍数较小的二维视觉镜头相比,达芬奇机器人的"眼睛",即具有放大10倍的高分辨率三维立体视觉镜头。

在减重手术中,不仅使主刀医生能够更清晰地观察到腹腔及胃部结构,也大大提高了手术过程中如切缘的判断以及缝合、打结等精细操作的精准度。

2. "化繁为简"

与传统的腹腔镜手术器械仅有两个或三个自由度相比,达芬奇机器人的"手",即内腕器械有七个自由度,类似于人类的手。

有助于在减重手术中于狭小的腹腔空间内更加灵活地进行胃、肠的分离和缝合,方便地完成传统腹腔镜减重手术器械很难完成的复杂手术动作。

3. 智能化操作

与传统的腹腔镜手术相比,达芬奇机器人外科医生控制台可以按比例缩小主刀医生的动作幅度,这意味着能够将手的大动作转换为较小的操作。

控制手柄可滤除外科医生手部的细微震颤,增加操作的稳定性,较传统腹腔镜减重手术更加精细和安全可靠,有助于完成传统腹腔镜手术器械很难完成的复杂手术动作。

达芬奇机器人的灵魂:主刀医生

虽然达芬奇机器人具有出血量少、创伤口不明显、术后恢复快、手术安全性高等优势,但前提是需要主刀医生去操作,因此能否发挥出达芬奇机器人的优势关键还在于主刀医生的技术和经验是否足够优秀。

47561591173506464

与传统手术相比,医生刚上手时会不习惯。但随着手术次数的增加和实践经验的积累,能够做到实时控制和纠正外科医生辅助动作过大带来的抖动,减少操作误差,这对医生的操作技术要求度非常高。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1819903, encodeId=400c1819903c2, content=<a href='/topic/show?id=f503100109df' target=_blank style='color:#2F92EE;'>#顺利完成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100109, encryptionId=f503100109df, topicName=顺利完成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Aug 20 07:07:21 CST 2020, time=2020-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317083, encodeId=a876131e08386, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322107, encodeId=627e132210e0d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554131, encodeId=a98f155413103, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583245, encodeId=81f81583245e4, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1819903, encodeId=400c1819903c2, content=<a href='/topic/show?id=f503100109df' target=_blank style='color:#2F92EE;'>#顺利完成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100109, encryptionId=f503100109df, topicName=顺利完成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Aug 20 07:07:21 CST 2020, time=2020-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317083, encodeId=a876131e08386, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322107, encodeId=627e132210e0d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554131, encodeId=a98f155413103, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583245, encodeId=81f81583245e4, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=)]
    2020-06-06 vera_1203
  3. [GetPortalCommentsPageByObjectIdResponse(id=1819903, encodeId=400c1819903c2, content=<a href='/topic/show?id=f503100109df' target=_blank style='color:#2F92EE;'>#顺利完成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100109, encryptionId=f503100109df, topicName=顺利完成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Aug 20 07:07:21 CST 2020, time=2020-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317083, encodeId=a876131e08386, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322107, encodeId=627e132210e0d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554131, encodeId=a98f155413103, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583245, encodeId=81f81583245e4, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=)]
    2020-06-06 xue8602
  4. [GetPortalCommentsPageByObjectIdResponse(id=1819903, encodeId=400c1819903c2, content=<a href='/topic/show?id=f503100109df' target=_blank style='color:#2F92EE;'>#顺利完成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100109, encryptionId=f503100109df, topicName=顺利完成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Aug 20 07:07:21 CST 2020, time=2020-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317083, encodeId=a876131e08386, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322107, encodeId=627e132210e0d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554131, encodeId=a98f155413103, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583245, encodeId=81f81583245e4, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1819903, encodeId=400c1819903c2, content=<a href='/topic/show?id=f503100109df' target=_blank style='color:#2F92EE;'>#顺利完成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100109, encryptionId=f503100109df, topicName=顺利完成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Thu Aug 20 07:07:21 CST 2020, time=2020-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317083, encodeId=a876131e08386, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1322107, encodeId=627e132210e0d, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554131, encodeId=a98f155413103, content=<a href='/topic/show?id=5ccb5051e37' target=_blank style='color:#2F92EE;'>#微创外科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50517, encryptionId=5ccb5051e37, topicName=微创外科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7af914505846, createdName=liuyong2985, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583245, encodeId=81f81583245e4, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat Jun 06 06:07:21 CST 2020, time=2020-06-06, status=1, ipAttribution=)]

相关资讯

Diabetes Care.:减重手术对早发性肥胖有效

越来越多的证据表明减重手术可以持续减轻体重、改善伴随疾病和延长生存期。早发性肥胖症患者和成年肥胖症患者接受减重手术是否同样获益呢?根据Diabetes Care发表的一项研究结果表明,20岁之前患肥胖

Eur Heart J:为减重手术正名:不仅是体重终结者,还能降低心脏病和中风风险!

3月18日,一项发表在《欧洲心脏杂志》的研究发现,针对肥胖患者的减重手术可明显降低其心脏病发作和中风风险,对于预防卒中和心脏病来说,手术比药物治疗、体重管理甚或这二者联合作用都有效得多。

2019 共识建议:减重手术后妊娠,围产期、产前和产后护理

本文的主要目的是针对减重手术后妊娠的应该管理和最佳护理提供循证指导。涉及减重手术后女性围产期、产期和产后的护理。

2019 AACE/TOS/ASMBS/OMA/ASA临床实践指南:减重手术围术期营养、代谢以及非手术支持

2019年11月,美国临床内分泌医师学会(AACE)联合多家学会更新发布了减重手术围术期营养、代谢以及非手术支持指南,专家组依据2013年至今的最新证据以及专家建议,对指南中的每项建议进行了评估和更新。主要更新内容涉及以肥胖为基础的慢性疾病并发症中心模型的情景化研究,基于细微差别和算法/检查表辅助的临床决策制定,新的减重手术程序,减重手术术后恢复等。

Hypertension:减重手术可降低顽固性高血压患病率

减重手术是降低血压(BP)的有效策略,但大多数证据依赖于诊室血压测量。Carlos A. Schiavon等研究者开展的这项研究,评估减重手术对24 h血压曲线、血压变异度和顽固性性高血压患病率的影响。

2019 加拿大共识声明:减重手术后加速康复

加拿大减重外科医生小组共同提出了减重手术后加速康复的共识声明,最终形成14条推荐意见,涉及术前咨询,肠道准备,术前禁食水,术前用药,血栓预防,备皮,麻醉,术中管理和术后营养以及随访等。